Skip to content
PipeBio logo

PipeBio

PipeBio is a YC Winter 2021 (W21) company. Based in Aarhus, Denmark; Remote. Team of 10.

  • AI-powered Drug Discovery
  • Machine Learning
  • SaaS

About PipeBio

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

PipeBio builds a cloud bioinformatics platform for antibody, peptide, and TCR drug discovery. Biologics scientists use it to process NGS and Sanger sequencing data, cluster and annotate candidates, screen for liabilities, and score hits for developability, replacing manual handoffs to bioinformaticians. Leads move directly into Benchling Biologics with annotation intact, eliminating data reformatting between discovery and registration.

Business model

SaaS subscription

Go-to-market

Biologics and antibody discovery teams at pharmaceutical and biotech organizations are the buyers; adoption starts through a demo request and connects into existing Benchling Biologics workflows.

From the Y Combinator listing

How PipeBio describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

PipeBio is a SaaS bioinformatics platform to develop antibody drugs.

Pipe|bio is the bioinformatics cloud for antibody / peptide screening & drug development. We enable scientists to analyze and manage massive amounts of DNA sequencing data themselves without the need for bioinformaticians or programmers. The software is highly visual and enables you to overlay and filter information from different sources across your organization; be it assay data, sequence data or other process metadata. Insights from past results can be used to guide new experiments and they get better as you upload more and more data. Team leads get oversight and these capabilities combined empower organizations to find better drugs, faster. We believe that science moves faster when scientists can curate and analyse their own data.

Facts

Industry
Healthcare / Healthcare -> Therapeutics
Location
Aarhus, Denmark; Remote
Team size
10
Status
Acquired
Stage
Early

Founders (2)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works